| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.50B | +635.3% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | — |
| Gross margin | 14.6% | Net margin 2.7% |
| Revenue Q/Q | +288.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.43B | 85.4% |
| SG&A | ¥0.06B | 11.2% |
| Tax & other | ¥-0.01B | -1.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
吴通控股 ・ 蓝英装备 ・ 博雅生物 ・ *ST三六五 ・ 利亚德 ・ 三诺生物 ・ 富春股份 ・ 海峡创新 ・ ST长方 ・ 同有科技 ・ 聚飞光电 ・ 云意电气
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies